Tapewire

Nasdaq · USD

KPTI

Karyopharm Therapeutics Inc.

Export transactions ↓
Tapewire entity
781
SEC CIK
0001503802
Parsed reports
479

Last 12 months

Inside the activity.

0 purchase rows · 20 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202602
Feb 202602
Mar 202606
Apr 202601
May 202606
Jun 202600
Jul 202601
Aug 202600
Sep 202601
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 12, 2020 Filed Oct 14, 2020 21:56 UTC
Kauffman MichaelDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 1,424 $0.00 Strike: $0.03 $0.00
Disclosure

SEC source: 0001209191-20-054822 · doc4.xml · derivative · entry 5

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 0

Underlying: Common Stock · 1,424 shares

Expires 2020-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

F3 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on November 1, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter.

Read SEC document
October 12, 2020 Filed Oct 14, 2020 21:56 UTC
Kauffman MichaelDirector · Chief Executive Officer
SaleCommon Stock 7,500 $14.89 $111,682.50
Disclosure

SEC source: 0001209191-20-054822 · doc4.xml · nonDerivative · entry 3

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 756,489

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.71 to $15.16, inclusive. The spouse of the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
October 12, 2020 Filed Oct 14, 2020 21:56 UTC
Kauffman MichaelDirector · Chief Executive Officer
Exercise / conversionCommon Stock 6,076 $0.03 $200.51
Disclosure

SEC source: 0001209191-20-054822 · doc4.xml · nonDerivative · entry 2

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 763,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

Read SEC document
October 12, 2020 Filed Oct 14, 2020 21:56 UTC
Kauffman MichaelDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,424 $0.03 $46.99
Disclosure

SEC source: 0001209191-20-054822 · doc4.xml · nonDerivative · entry 1

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 757,913

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

Read SEC document
October 12, 2020 Filed Oct 14, 2020 21:54 UTC
Shacham SharonPresident & CSO
Exercise / conversionStock Option (right to buy) · Derivative 6,076 $0.00 Strike: $0.03 $0.00
Disclosure

SEC source: 0001209191-20-054821 · doc4.xml · derivative · entry 6

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,076 shares

Expires 2020-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on November 1, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter.

Read SEC document
October 12, 2020 Filed Oct 14, 2020 21:54 UTC
Shacham SharonPresident & CSO
Exercise / conversionStock Option (right to buy) · Derivative 1,424 $0.00 Strike: $0.03 $0.00
Disclosure

SEC source: 0001209191-20-054821 · doc4.xml · derivative · entry 5

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,424 shares

Expires 2020-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on November 1, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter.

Read SEC document
October 12, 2020 Filed Oct 14, 2020 21:54 UTC
Shacham SharonPresident & CSO
SaleCommon Stock 7,500 $14.89 $111,682.50
Disclosure

SEC source: 0001209191-20-054821 · doc4.xml · nonDerivative · entry 3

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 756,489

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.71 to $15.16, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
October 12, 2020 Filed Oct 14, 2020 21:54 UTC
Shacham SharonPresident & CSO
Exercise / conversionCommon Stock 6,076 $0.03 $200.51
Disclosure

SEC source: 0001209191-20-054821 · doc4.xml · nonDerivative · entry 2

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 763,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
October 12, 2020 Filed Oct 14, 2020 21:54 UTC
Shacham SharonPresident & CSO
Exercise / conversionCommon Stock 1,424 $0.03 $46.99
Disclosure

SEC source: 0001209191-20-054821 · doc4.xml · nonDerivative · entry 1

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 757,913

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
September 08, 2020 Filed Sep 10, 2020 12:49 UTC
Primiano Christopher BrettEVP, CBO, GC & Secretary
Exercise / conversionStock Option (right to buy) · Derivative 10,054 $0.00 Strike: $6.54 $0.00
Disclosure

SEC source: 0001209191-20-049920 · doc4.xml · derivative · entry 3

Primiano Christopher Brett · CIK 0001603510 · EVP, CBO, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,054 shares

Expires 2026-01-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 15, 2017, and the remaining 75% vested in 36 equal monthly installments thereafter.

Read SEC document
September 08, 2020 Filed Sep 10, 2020 12:49 UTC
Primiano Christopher BrettEVP, CBO, GC & Secretary
SaleCommon Stock 10,054 $14.98 $150,608.92
Disclosure

SEC source: 0001209191-20-049920 · doc4.xml · nonDerivative · entry 2

Primiano Christopher Brett · CIK 0001603510 · EVP, CBO, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,649

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
September 08, 2020 Filed Sep 10, 2020 12:49 UTC
Primiano Christopher BrettEVP, CBO, GC & Secretary
Exercise / conversionCommon Stock 10,054 $6.54 $65,753.16
Disclosure

SEC source: 0001209191-20-049920 · doc4.xml · nonDerivative · entry 1

Primiano Christopher Brett · CIK 0001603510 · EVP, CBO, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,703

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
August 28, 2020 Filed Aug 31, 2020 22:03 UTC GrantNonstatutory Stock Option (right to buy) · Derivative 32,800 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-20-048840 · doc4.xml · derivative · entry 1

Oliger Christy J. · CIK 0001822092 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,800

Underlying: Common Stock · 32,800 shares

Expires 2030-08-27

F1 · derivative.exercise_date: This option was granted on August 28, 2020. The shares underlying this option vest as to one-third (1/3) of the shares on August 28, 2021 and as to the remaining two-thirds (2/3) of the shares in 24 equal monthly installments thereafter.

Read SEC document
August 26, 2020 Filed Aug 27, 2020 16:00 UTC
DEMAREE JOHNChief Commercial Officer
PurchaseCommon Stock 7,500 $14.54 $109,012.50
Disclosure

SEC source: 0001209191-20-048515 · doc4.xml · nonDerivative · entry 1

DEMAREE JOHN · CIK 0001744959 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Read SEC document
August 17, 2020 Filed Aug 18, 2020 22:07 UTC
Kauffman MichaelDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 1,477 $0.00 Strike: $0.03 $0.00
Disclosure

SEC source: 0001209191-20-047279 · doc4.xml · derivative · entry 4

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 6,076

Underlying: Common Stock · 1,477 shares

Expires 2020-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

F2 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on November 1, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter.

Read SEC document
August 17, 2020 Filed Aug 18, 2020 22:07 UTC
Kauffman MichaelDirector · Chief Executive Officer
SaleCommon Stock 1,477 $15.00 $22,155.00
Disclosure

SEC source: 0001209191-20-047279 · doc4.xml · nonDerivative · entry 2

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 756,489

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

Read SEC document
August 17, 2020 Filed Aug 18, 2020 22:07 UTC
Kauffman MichaelDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,477 $0.03 $48.74
Disclosure

SEC source: 0001209191-20-047279 · doc4.xml · nonDerivative · entry 1

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 757,966

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

Read SEC document
August 17, 2020 Filed Aug 18, 2020 22:05 UTC
Shacham SharonPresident & CSO
Exercise / conversionStock Option (right to buy) · Derivative 1,477 $0.00 Strike: $0.03 $0.00
Disclosure

SEC source: 0001209191-20-047278 · doc4.xml · derivative · entry 4

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,076

Underlying: Common Stock · 1,477 shares

Expires 2020-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on November 1, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter.

Read SEC document
August 17, 2020 Filed Aug 18, 2020 22:05 UTC
Shacham SharonPresident & CSO
SaleCommon Stock 1,477 $15.00 $22,155.00
Disclosure

SEC source: 0001209191-20-047278 · doc4.xml · nonDerivative · entry 2

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 756,489

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
August 17, 2020 Filed Aug 18, 2020 22:05 UTC
Shacham SharonPresident & CSO
Exercise / conversionCommon Stock 1,477 $0.03 $48.74
Disclosure

SEC source: 0001209191-20-047278 · doc4.xml · nonDerivative · entry 1

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 757,966

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
July 15, 2020 Filed Jul 17, 2020 20:26 UTC
Kauffman MichaelDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $0.03 $0.00
Disclosure

SEC source: 0001209191-20-042845 · doc4.xml · derivative · entry 4

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 1,424

Underlying: Common Stock · 7,500 shares

Expires 2020-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

F3 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on November 1, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter.

Read SEC document
July 15, 2020 Filed Jul 17, 2020 20:26 UTC
Kauffman MichaelDirector · Chief Executive Officer
SaleCommon Stock 7,500 $19.43 $145,722.75
Disclosure

SEC source: 0001209191-20-042845 · doc4.xml · nonDerivative · entry 2

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 756,489

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.17 to $19.86, inclusive. The spouse of the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
July 15, 2020 Filed Jul 17, 2020 20:26 UTC
Kauffman MichaelDirector · Chief Executive Officer
Exercise / conversionCommon Stock 7,500 $0.03 $247.50
Disclosure

SEC source: 0001209191-20-042845 · doc4.xml · nonDerivative · entry 1

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 763,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

Read SEC document
July 15, 2020 Filed Jul 17, 2020 20:24 UTC
Shacham SharonPresident & CSO
Exercise / conversionStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $0.03 $0.00
Disclosure

SEC source: 0001209191-20-042840 · doc4.xml · derivative · entry 4

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,424

Underlying: Common Stock · 7,500 shares

Expires 2020-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on November 1, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter.

Read SEC document
July 15, 2020 Filed Jul 17, 2020 20:24 UTC
Shacham SharonPresident & CSO
SaleCommon Stock 7,500 $19.43 $145,722.75
Disclosure

SEC source: 0001209191-20-042840 · doc4.xml · nonDerivative · entry 2

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 756,489

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.17 to $19.86, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
July 15, 2020 Filed Jul 17, 2020 20:24 UTC
Shacham SharonPresident & CSO
Exercise / conversionCommon Stock 7,500 $0.03 $247.50
Disclosure

SEC source: 0001209191-20-042840 · doc4.xml · nonDerivative · entry 1

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 763,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
July 15, 2020 Filed Nov 5, 2020 01:16 UTC
Shah JatinEVP, Chief Medical Officer
SaleCommon Stock 589 $19.46 $11,461.94
Disclosure

SEC source: 0001209191-20-057052 · doc4.xml · nonDerivative · entry 2

Shah Jatin · CIK 0001782186 · EVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,229

F2 · kind: This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.

F3 · balance_after: Includes 646 shares acquired by the reporting person under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on October 31, 2020.

Read SEC document
July 11, 2020 Filed Nov 5, 2020 01:16 UTC
Shah JatinEVP, Chief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 2,413 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-057052 · doc4.xml · derivative · entry 3

Shah Jatin · CIK 0001782186 · EVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,237

Underlying: Common Stock · 2,413 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis.

F4 · derivative.exercise_date: On July 11, 2019, the reporting person was granted 9,650 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. 25% of the restricted stock units vested on July 11, 2020. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date.

F4 · derivative.expiration_date: On July 11, 2019, the reporting person was granted 9,650 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. 25% of the restricted stock units vested on July 11, 2020. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date.

Read SEC document
July 11, 2020 Filed Nov 5, 2020 01:16 UTC
Shah JatinEVP, Chief Medical Officer
Exercise / conversionCommon Stock 2,413 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-057052 · doc4.xml · nonDerivative · entry 1

Shah Jatin · CIK 0001782186 · EVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,172

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis.

Read SEC document
July 10, 2020 Filed Jul 13, 2020 22:45 UTC
Kauffman MichaelDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $4.75 $0.00
Disclosure

SEC source: 0001209191-20-042310 · doc4.xml · derivative · entry 6

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 333,561

Underlying: Common Stock · 7,500 shares

Expires 2023-09-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F6 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter.

Read SEC document
July 10, 2020 Filed Jul 13, 2020 22:45 UTC
Kauffman MichaelDirector · Chief Executive Officer
SaleCommon Stock 300 $19.71 $5,912.01
Disclosure

SEC source: 0001209191-20-042310 · doc4.xml · nonDerivative · entry 3

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 555,122

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.69 to $19.73, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
July 10, 2020 Filed Jul 13, 2020 22:45 UTC
Kauffman MichaelDirector · Chief Executive Officer
SaleCommon Stock 7,200 $18.98 $136,627.20
Disclosure

SEC source: 0001209191-20-042310 · doc4.xml · nonDerivative · entry 2

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 555,422

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.67 to $19.64, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
July 10, 2020 Filed Jul 13, 2020 22:45 UTC
Kauffman MichaelDirector · Chief Executive Officer
Exercise / conversionCommon Stock 7,500 $4.75 $35,640.00
Disclosure

SEC source: 0001209191-20-042310 · doc4.xml · nonDerivative · entry 1

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 562,622

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
July 10, 2020 Filed Jul 13, 2020 22:43 UTC
Shacham SharonPresident & CSO
Exercise / conversionStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $4.75 $0.00
Disclosure

SEC source: 0001209191-20-042309 · doc4.xml · derivative · entry 7

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 333,561

Underlying: Common Stock · 7,500 shares

Expires 2023-09-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

F6 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter.

Read SEC document
July 10, 2020 Filed Jul 13, 2020 22:43 UTC
Shacham SharonPresident & CSO
SaleCommon Stock 300 $19.71 $5,912.01
Disclosure

SEC source: 0001209191-20-042309 · doc4.xml · nonDerivative · entry 5

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 555,122

F3 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

F5 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.69 to $19.73, inclusive. The spouse of the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
July 10, 2020 Filed Jul 13, 2020 22:43 UTC
Shacham SharonPresident & CSO
SaleCommon Stock 7,200 $18.98 $136,627.20
Disclosure

SEC source: 0001209191-20-042309 · doc4.xml · nonDerivative · entry 4

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 555,422

F3 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

F4 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.67 to $19.64, inclusive. The spouse of the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
July 10, 2020 Filed Jul 13, 2020 22:43 UTC
Shacham SharonPresident & CSO
Exercise / conversionCommon Stock 7,500 $4.75 $35,640.00
Disclosure

SEC source: 0001209191-20-042309 · doc4.xml · nonDerivative · entry 3

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 562,622

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

Read SEC document
July 09, 2020 Filed Jul 13, 2020 22:45 UTC
Kauffman MichaelDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $4.75 $0.00
Disclosure

SEC source: 0001209191-20-042310 · doc4.xml · derivative · entry 7

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 377,803

Underlying: Common Stock · 7,500 shares

Expires 2023-09-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

F6 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter.

Read SEC document
July 09, 2020 Filed Jul 13, 2020 22:45 UTC
Kauffman MichaelDirector · Chief Executive Officer
SaleCommon Stock 7,500 $19.53 $146,487.00
Disclosure

SEC source: 0001209191-20-042310 · doc4.xml · nonDerivative · entry 5

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 756,489

F4 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

F5 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.30 to $19.75, inclusive. The spouse of the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
July 09, 2020 Filed Jul 13, 2020 22:45 UTC
Kauffman MichaelDirector · Chief Executive Officer
Exercise / conversionCommon Stock 7,500 $4.75 $35,640.00
Disclosure

SEC source: 0001209191-20-042310 · doc4.xml · nonDerivative · entry 4

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 763,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

Read SEC document
July 09, 2020 Filed Jul 13, 2020 22:43 UTC
Shacham SharonPresident & CSO
Exercise / conversionStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $4.75 $0.00
Disclosure

SEC source: 0001209191-20-042309 · doc4.xml · derivative · entry 6

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 377,803

Underlying: Common Stock · 7,500 shares

Expires 2023-09-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F6 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter.

Read SEC document
July 09, 2020 Filed Jul 13, 2020 22:43 UTC
Shacham SharonPresident & CSO
SaleCommon Stock 7,500 $19.53 $146,487.00
Disclosure

SEC source: 0001209191-20-042309 · doc4.xml · nonDerivative · entry 2

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 756,489

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.30 to $19.75, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
July 09, 2020 Filed Jul 13, 2020 22:43 UTC
Shacham SharonPresident & CSO
Exercise / conversionCommon Stock 7,500 $4.75 $35,640.00
Disclosure

SEC source: 0001209191-20-042309 · doc4.xml · nonDerivative · entry 1

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 763,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
June 22, 2020 Filed Jun 24, 2020 20:07 UTC
Kauffman MichaelDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $0.03 $0.00
Disclosure

SEC source: 0001209191-20-038718 · doc4.xml · derivative · entry 4

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 8,924

Underlying: Common Stock · 7,500 shares

Expires 2020-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

F2 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on November 1, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter.

Read SEC document
June 22, 2020 Filed Jun 24, 2020 20:07 UTC
Kauffman MichaelDirector · Chief Executive Officer
SaleCommon Stock 7,500 $20.00 $150,000.00
Disclosure

SEC source: 0001209191-20-038718 · doc4.xml · nonDerivative · entry 2

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 756,489

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

Read SEC document
June 22, 2020 Filed Jun 24, 2020 20:07 UTC
Kauffman MichaelDirector · Chief Executive Officer
Exercise / conversionCommon Stock 7,500 $0.03 $247.50
Disclosure

SEC source: 0001209191-20-038718 · doc4.xml · nonDerivative · entry 1

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 763,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

Read SEC document
June 22, 2020 Filed Jun 24, 2020 20:05 UTC
Shacham SharonPresident & CSO
Exercise / conversionStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $0.03 $0.00
Disclosure

SEC source: 0001209191-20-038717 · doc4.xml · derivative · entry 4

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,924

Underlying: Common Stock · 7,500 shares

Expires 2020-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on November 1, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter.

Read SEC document
June 22, 2020 Filed Jun 24, 2020 20:05 UTC
Shacham SharonPresident & CSO
SaleCommon Stock 7,500 $20.00 $150,000.00
Disclosure

SEC source: 0001209191-20-038717 · doc4.xml · nonDerivative · entry 2

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 756,489

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
June 22, 2020 Filed Jun 24, 2020 20:05 UTC
Shacham SharonPresident & CSO
Exercise / conversionCommon Stock 7,500 $0.03 $247.50
Disclosure

SEC source: 0001209191-20-038717 · doc4.xml · nonDerivative · entry 1

Shacham Sharon · CIK 0001588438 · President & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 763,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
June 15, 2020 Filed Jun 17, 2020 20:07 UTC
Kauffman MichaelDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 357 $0.00 Strike: $0.03 $0.00
Disclosure

SEC source: 0001209191-20-037229 · doc4.xml · derivative · entry 7

Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 0

Underlying: Common Stock · 357 shares

Expires 2020-10-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.

F4 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on October 22, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.